1.
Blood
; 140:4364-4365, 2022.
Article
in English
| ScienceDirect | ID: covidwho-2120165
2.
Cancer Cell
; 39(11): 1442-1444, 2021 11 08.
Article
in English
| MEDLINE | ID: covidwho-1525716
Subject(s)
COVID-19 Vaccines/administration & dosage , COVID-19/prevention & control , Immunity, Cellular/drug effects , Immunogenicity, Vaccine , Multiple Myeloma/immunology , SARS-CoV-2/drug effects , Spike Glycoprotein, Coronavirus/immunology , 2019-nCoV Vaccine mRNA-1273 , Antibodies, Viral/blood , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , B-Lymphocytes/virology , BNT162 Vaccine , COVID-19/diagnosis , COVID-19/immunology , COVID-19/virology , Case-Control Studies , Cytokines/blood , Host-Pathogen Interactions , Humans , Immunoglobulin G/blood , Lymphocyte Activation/drug effects , Multiple Myeloma/diagnosis , SARS-CoV-2/immunology , SARS-CoV-2/pathogenicity , T-Lymphocytes/drug effects , T-Lymphocytes/immunology , T-Lymphocytes/virology , Treatment Outcome , Vaccination
3.
Cancer Cell
; 39(8): 1028-1030, 2021 08 09.
Article
in English
| MEDLINE | ID: covidwho-1283965
Subject(s)
COVID-19 , Multiple Myeloma , Antibody Formation , Humans , Multiple Myeloma/drug therapy , Multiple Myeloma/genetics , RNA , SARS-CoV-2 , Vaccination
4.
N Engl J Med
; 384(14): 1372-1374, 2021 04 08.
Article
in English
| MEDLINE | ID: covidwho-1124409